Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D MOORE

Showing results (561-570 of 3,355) with videos related to

Pageof 336
Sort By:
British Journal of Clinical Pharmacology|April 24, 1999
Is reporting rate a good predictor of risks associated with drugs?C Pierfitte, B Bégaud, R Lagnaoui, et al.
Physician Executive|April 7, 1996
Making integrated health care workD C Coddington, K D Moore, E A Fischer
The New England Journal of Medicine|September 21, 1995
Race, sex, drug use, and progression of human immunodeficiency virus diseaseR E Chaisson, J C Keruly, R D Moore
Neuroscience Letters|November 26, 1993
Seizure-like activity disrupts LTP in vitroS D Moore, D S Barr, W A Wilson
American Journal of Clinical Pathology|October 1, 1980
Analytic clinical laboratory precision--state of the art for thirty-one analysisJ W Ross, M D Fraser, T D Moore
The Journal of Infectious Diseases|January 1, 1984
Risk factors for the development of auditory toxicity in patients receiving aminoglycosidesR D Moore, C R Smith, P S Lietman
American Journal of Dentistry|June 1, 1996
Pulpal response to dentin etched with 10% phosphoric acidR O Gilpatrick, W Johnson, D Moore, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 1, 1995
Clinical spectrum of herpes zoster in adults infected with human immunodeficiency virusM J Glesby, R D Moore, R E Chaisson
Journal of Abnormal Psychology|February 1, 1996
Diazepam blocks fear-potentiated startle in humansC J Patrick, B D Berthot, J D Moore
Environmental Toxicology|April 29, 2009
Malathion-induced oxidative stress, cytotoxicity, and genotoxicity in human liver carcinoma (HepG2) cellsPamela D Moore, Clement G Yedjou, Paul B Tchounwou
Pageof 336

Showing results (561-570 of 3,355) with videos related to

Sort By:
Pageof 336
British Journal of Clinical Pharmacology|April 24, 1999
Is reporting rate a good predictor of risks associated with drugs?C Pierfitte, B Bégaud, R Lagnaoui, et al.
Physician Executive|April 7, 1996
Making integrated health care workD C Coddington, K D Moore, E A Fischer
The New England Journal of Medicine|September 21, 1995
Race, sex, drug use, and progression of human immunodeficiency virus diseaseR E Chaisson, J C Keruly, R D Moore
Neuroscience Letters|November 26, 1993
Seizure-like activity disrupts LTP in vitroS D Moore, D S Barr, W A Wilson
American Journal of Clinical Pathology|October 1, 1980
Analytic clinical laboratory precision--state of the art for thirty-one analysisJ W Ross, M D Fraser, T D Moore
The Journal of Infectious Diseases|January 1, 1984
Risk factors for the development of auditory toxicity in patients receiving aminoglycosidesR D Moore, C R Smith, P S Lietman
American Journal of Dentistry|June 1, 1996
Pulpal response to dentin etched with 10% phosphoric acidR O Gilpatrick, W Johnson, D Moore, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 1, 1995
Clinical spectrum of herpes zoster in adults infected with human immunodeficiency virusM J Glesby, R D Moore, R E Chaisson
Journal of Abnormal Psychology|February 1, 1996
Diazepam blocks fear-potentiated startle in humansC J Patrick, B D Berthot, J D Moore
Environmental Toxicology|April 29, 2009
Malathion-induced oxidative stress, cytotoxicity, and genotoxicity in human liver carcinoma (HepG2) cellsPamela D Moore, Clement G Yedjou, Paul B Tchounwou
Pageof 336